Výsledky vyhledávání - "T. Kiskartalyi"

Phase III Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Docetaxel (AC→T) with Doxorubicin and Cyclophosphamide Followed by Docetaxel and Trastuzumab (AC→TH) with Docetaxel, Carboplatin and Trastuzumab (TCH) in Her2neu Positive Early Breast Cancer Patients: BCIRG 006 Study

Autor: Marc Buyse, MC Liu, Carla I. Falkson, TA Shiftan, Nicholas J. Robert, V. Wilson, V. Valero, John R. Mackey, John Crown, Michael F. Press, Miguel Martín, J. Rolski, Wolfgang Eiermann, Tamás Pintér, DJ Slamon, T. Kiskartalyi, V. Landreau, Arlene Chan, S. Olsen, Tadeusz Pienkowski, Tommy Fornander

Publikováno v: Cancer Research. 69:62-62

Background: Evaluation of the long-term benefit of biologically-based regimens of trastuzumab in the early breast cancer population, and optimization of trastuzumab integration to maximize efficacy and minimize cardiac toxicity.Material and Methods:

Vyhledávací nástroje:

Upřesnit hledání